IFNB1 and melanoma: Specifically, IFN-β treatment of CD133+ murine and human melanoma cells in soft 3D fibrin gels induced G0/G1 cell cycle arrest, expression of dormancy markers, decreased glucose consumption and higher resistance to chemotherapy, many of these features being hallmarks of CSCs.